Bladder Cancer, also known as urinary bladder cancer, is related to bladder urothelial carcinoma and transitional cell carcinoma. An important gene associated with Bladder Cancer is FGFR3 (Fibroblast Growth Factor Receptor 3), and among its related pathways/superpathways are Gene expression (Transcription) and Infectious disease. The drugs Droperidol and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include lymph node and prostate, and related phenotypes are transitional cell carcinoma of the bladder and bladder neoplasm